Jackson, S., Baker, E. H., Gross, A. M., Whitcomb, P., Baldwin, A., Derdak, J., . . . Dombi, E. (2020). The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas. Neurooncol Adv.
Citação norma ChicagoJackson, Sadhana, et al. "The MEK Inhibitor Selumetinib Reduces Spinal Neurofibroma Burden in Patients With NF1 and Plexiform Neurofibromas." Neurooncol Adv 2020.
MLA CitationJackson, Sadhana, et al. "The MEK Inhibitor Selumetinib Reduces Spinal Neurofibroma Burden in Patients With NF1 and Plexiform Neurofibromas." Neurooncol Adv 2020.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.